The humanoid robotics industry finds itself shrouded in the ominous clouds of bursting bubbles, a phenomenon that many investors dreadA prime example of this trend is UBTech, often heralded as the "first humanoid robotics stock," which has seen a dramatic decline, falling for four consecutive trading days and erasing over 45% of its market value, equivalent to a staggering 18 billion HKDThis downturn has led to reflections on the nature of market bubbles, particularly the undiscussed consensus that a price drop of more than 30% within a short duration tends to signal possible disasterThe recent plummet of UBTech's share price starkly illustrates signs of such a bubble burst looming overhead.

The catalyst for this meltdown appears to be an announcement regarding the termination of a consensus action agreement among shareholders, which implies significant disagreement among themWhile differing opinions among shareholders about a company's strategic direction is a commonplace occurrence in the business world, the sheer scale of UBTech's stock price drop raises the question: why trigger such a calamity this time around?

To answer this, we must delve deeper into UBTech's unique position within the humanoid robotics sector

Advertisements

As a key benchmark enterprise, the firm's movements resonate throughout the capital markets, influencing investor confidence and expectations toward the entire industryThus, this stock surge is not merely a consequence of internal shareholder disputes, but also a manifestation of dwindling trust in the long-term viability and commercial success of humanoid robotics.

After a whirlwind of speculative excitement, investors are now hungry for tangible business returns and mature commercial modelsHowever, the commercial journey for humanoid robots has been more staggering than anticipated, leading to a gradual decline in enthusiasm, which is now evolving into disappointment and anxietyThe spectacular fall of UBTech onto the stage of capital markets begs a profound question that lingers in the minds of many: Are humanoid robots a glimpse into a tangible technological future, or merely a fleeting display of fireworks in the realm of capital?

On December 29th, the announcement that UBTech would terminate its consensus action agreement sent ripples through the stock market

Advertisements

Chairman Zhou Jian, alongside other shareholders, stated that they would no longer grant Zhou the authority to vote on behalf of them at shareholder meetingsThis kind of agreement typically concerns significant shareholders collaborating to improve governance efficiency within a company.

Analyzing this turn of events, Bai Wenxi, vice-chairman of the China Capital Alliance, notes that the dissolution of such agreements could significantly impact the company's control structure and alter public perception of its long-term strategic directionIt also raises fears of internal disharmony among management, stirring investor emotions and leading to chaotic stock market reactions.

The origins of this turbulence can be traced back to UBTech's funding journeyWith the recent surge in developments in general artificial intelligence and the entry of giants like Tesla into the humanoid robotics sector, interest and investment flooded into the industry

Advertisements

In response to this heightened market optimism, UBTech attracted multiple rounds of financing throughout its trajectoryIts journey commenced in December 2015, when iFlytek acquired a 3% stake in UBTech for 9 million USD, officially bringing UBTech to the forefront of major investment firms’ radarsBy May 2018, the company announced the completion of its Series C funding, achieving a post-funding valuation of 5 billion USD and attracting prominent investors, including Tencent and the Industrial and Commercial Bank of China.

Even after listing on the Hong Kong Stock Exchange, UBTech engaged in three additional rounds of financing, gathering a total of approximately 1.082 billion HKD, outstripping the capital raised during its IPOHowever, along with the influx of funds came the emergence of diverse opinions among shareholders—should the company persist with high-risk spending on R&D or pivot towards prioritizing cash flow? Should it pursue aggressive pricing tactics to expand its market or stabilize its operations to enhance profitability, thus maintaining investor confidence?

In the early stages, amidst the push to reach a listing goal, shareholders might have been able to postpone debates by agreeing on a temporary course of action

• Promoting Safe and Orderly Development of Nuclear Energy
• Nvidia Loses $240B in Market Value Overnight
• U.S. JOLTS Job Openings Exceed Expectations
• Elevating the Full Chain of China's Automotive Industry
• Anthropic Seeks $2B at $60B Valuation

Yet, the inevitable erosion of time has rendered such agreements unsustainableRecent reports suggest that the varied opinions concerning UBTech's future among key shareholders reflect a larger ongoing disagreement: some advocate for continued investment in R&D to secure a technological lead, while others argue for a focus on achieving commercialization.

As the internal schism leads to disarray within decision-making processes, UBTech could face severe negative impacts on operational efficiencies and corporate healthThe boardroom has witnessed confrontations between formerly united camps, which are now splintering under the weight of strategic differencesIn response to inquiries about this divisive situation, UBTech reassured the market that founder Zhou Jian has publicized a long-term lock-up agreement concerning shares and respects the differing approaches of shareholders regarding Pre-IPO stock disposals.

Meanwhile, alongside the shareholder disputes, UBTech's performance remains a significant burden weighing heavily on investors' minds

Founded in 2012, UBTech has been diligently cultivating all-encompassing technologies in humanoid roboticsProducts include educational and logistical robots tailored for businesses, in addition to consumer-grade smart robots such as the Walker series, which has been synonymous with UBTech’s innovative edge.

However, this flagship Walker line, despite its cutting-edge capabilities, struggles to penetrate markets effectivelyWithin its broader business portfolio, the Walker robots fall under the category of “customized intelligent robots”—a segment that, according to Wind data, saw revenues drop from 90 million to 70 million yuan between 2022 and 2023. This decline is starkly contrasted by a modest resurgence anticipated in the first half of 2024, reflecting a mere fraction of its full potential at only 19% of total revenue.

Interestingly, UBTech’s robust revenue stream is attributed primarily to its education robots

Reports by Frost & Sullivan indicate that UBTech secured a market share of 22.5% in the educational space in 2022, making it the dominant player domesticallyYet, that robust share is also witnessing a precarious descent—though it constituted over 51% of overall revenue two years prior, the contribution dipped to just over 30% in the last year, while revenues from educational robots plummeted from above 700 million yuan to less than 400 million in 2023.

What is alarming, however, is the reliance on a limited number of clients, with the largest customer groups accounting for 66.5% and 52.2% of revenue respectively in recent yearsFollowing a reasonable hypothesis, these clients are likely government educational institutions, underscoring a risk: any adverse shifts in procurement plans due to policy changes or budgetary constraints could lead to stagnation in revenue growthWhat remains troubling is the apparent failure of UBTech to attract interest from individual consumers successfully.

Years of investment and the reputation of advanced technology are intertwined in the labyrinth of business—UBTech's lavish expectations have not crystallized into profitable operations

The company's revenues soared from 740 million yuan in 2020 to 1.056 billion in 2023, but it has simultaneously expanded its losses alarmingly, escalating from 707 million to over 1.234 billion within the same time frameThe stark contrast in the first half of 2024 paints a grim reality: the company incurred losses exceeding its revenues—the fiscal imbalance reveals expenses outweighing operational income.

This ongoing loss spiral may explain why, despite being a publicly-listed company, UBTech remains in desperate search of further capital infusionAs financing efforts intensify, a plethora of investors enters the arena with varying interests, resulting in heightened stakesThe recent stock crash echoes the compounded pressures from shareholders, leading to escalating tensions.

Reflecting on the broader landscape, we observe that UBTech’s challenges resonate within the humanoid robotics industry, particularly underscored by foundational shifts seen throughout 2022 and into 2023. Tesla's unveiling of its Optimus robot prototype, which struggled even to walk without assistance initially, suggested immense potential

Fast-forward to 2023, where now Optimus can nimbly handle an egg with precision.

At year's end, two significant milestones further intensified excitement within the humanoid robotics sector: the release of the "Guidance for Innovative Development of Humanoid Robotics" by China's Ministry of Industry and Information Technology, providing policy direction, and UBTech’s triumphant entry into the Hong Kong stock market, both contributing to a renewed sense of optimism amongst key stakeholders.

This flurry of activity seemed to galvanize a collective enthusiasm; stakeholders viewed 2024 as a pivotal moment for the industry's accelerated developmentYet, skepticism only grew as the reality highlighted the inherent difficulties faced by this burgeoning sector, with commercial viability posing substantial hindrancesThe challenges faced by Boston Dynamics and UBTech reveal that despite the technological allure, significant obstacles remain in transitioning from concept to viable market product.

While many companies in the humanoid sector proclaim readiness for mass production, like Yushu Technology and EX Robotics—each introducing new humanoid robots—many fail to effectively capture attention due to perceived limitations in functionality or inflated costs that still impede commercial success.

Ultimately, the core of these commercial complications lies in the steep costs associated with developing humanoid robots

Take Boston Dynamics' flagship Atlas model, once considered a symbol of technological prowess, but priced around an insurmountable 2 million USD, rendering widespread commercialization virtually impossibleTesla faces somewhat similar hurdles, with their Optimus robots estimated to cost around 100,000 USD, potentially limiting their market reach despite the appeal to innovate.

On the other hand, UBTech offers products at more accessible price points; their educational robots are priced below 15,000 yuan, while consumer robots dip below 2,000 yuanHowever, the premium Walker series, priced inate hundreds of thousands, struggles to achieve market penetration, reflecting a critical gap in their economic stratagem.

Pundits, including Tesla’s Elon Musk, project that humanoid robot costs could drop to 20,000-30,000 USD in the near future, igniting hope for industry enthusiasts